OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Siglecs as Therapeutic Targets in Cancer
Jackwee Lim, Duygu Sari, Tanaya Bagga
Biology (2021) Vol. 10, Iss. 11, pp. 1178-1178
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The role of sialylation in gynecologic cancers
Szu‐Ting Yang, Chia-Hao Liu, Wei‐Ting Chao, et al.
Taiwanese Journal of Obstetrics and Gynecology (2023) Vol. 62, Iss. 5, pp. 651-654
Open Access | Times Cited: 27

Gangliosides as Siglec ligands
Ronald L. Schnaar
Glycoconjugate Journal (2023) Vol. 40, Iss. 2, pp. 159-167
Closed Access | Times Cited: 24

The tumor microenvironment: shaping cancer progression and treatment response
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 13

Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors
Kelli A. McCord, Chao Wang, Mirjam Anhalt, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 315-330
Open Access | Times Cited: 12

The intriguing roles of Siglec family members in the tumor microenvironment
Kui-Ying Jiang, Lili Qi, Fubiao Kang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 28

Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
Ashok Kumar Jangid, Sung Jun Kim, Kyobum Kim
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 15

Human sialoglycan ligands for immune inhibitory Siglecs
Anabel Gonzalez-Gil, T. August Li, Jean Kim, et al.
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101110-101110
Open Access | Times Cited: 19

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease
Silva Herzog, Paraskevi C. Fragkou, Borros Arneth, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19

Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages
Nhan Phan Tran, Phuong Tran, So‐Yeol Yoo, et al.
Biomaterials Advances (2023) Vol. 154, pp. 213606-213606
Closed Access | Times Cited: 12

Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite
Annalise Bond, Meghan A. Morrissey
Journal of Cell Science (2025) Vol. 138, Iss. 1
Closed Access

Understanding the Glycosylation Pathways Involved in the Biosynthesis of the Sulfated Glycan Ligands for Siglecs
Jaesoo Jung, Edward N. Schmidt, Hua-Chien Chang, et al.
ACS Chemical Biology (2025)
Closed Access

Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access

Siglec-targeted liposomes to identify sialoglycans present on fungal pathogens
Suresh Ambati, Quanita J. Choudhury, J. PETER, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access

Tumor-Derived Extracellular Vesicles: Hijacking T cell Function through Exhaustion
Renhua Guo, Ping Wang
Pathology - Research and Practice (2025), pp. 155948-155948
Closed Access

Aberrant protein glycosylation in the colon adenoma-cancer sequence: Colorectal cancer mechanisms and clinical implications
Yingli He, Ping Yang, Jun Yan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167853-167853
Closed Access

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
Ramya Ephraim, Jack Feehan, Sarah Fraser, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6131-6131
Open Access | Times Cited: 18

Role of tumor cell sialylation in pancreatic cancer progression
Michael P. Marciel, Barnita Haldar, Jihye Hwang, et al.
Advances in cancer research (2022), pp. 123-155
Open Access | Times Cited: 14

A Structural-Reporter Group to Determine the Core Conformation of Sialyl Lewisx Mimetics
Beatrice Wagner, Florian Binder, Xiaohua Jiang, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2595-2595
Open Access | Times Cited: 8

Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting
Ashok Kumar Jangid, Sungjun Kim, Hee Won Park, et al.
Biomacromolecules (2023) Vol. 25, Iss. 1, pp. 222-237
Closed Access | Times Cited: 8

Unravelling CD24Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies
Rudradeep Hazra, Soumyadeep Chattopadhyay, Arijit Mallick, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 442-469
Closed Access | Times Cited: 2

The Ying and Yang of Ganglioside Function in Cancer
Cara‐Lynne Schengrund
Cancers (2023) Vol. 15, Iss. 22, pp. 5362-5362
Open Access | Times Cited: 6

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells
Emily Archer Goode, Margarita Orozco‐Moreno, Kirsty Hodgson, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2953-2953
Open Access | Times Cited: 1

Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis
Danzan Mansorunov, Н. В. Апанович, П. В. Апанович, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2370-2370
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top